首页> 外文期刊>BMC Cardiovascular Disorders >Prognostic dynamic nomogram integrated with metabolic acidosis for in-hospital mortality and organ malperfusion in acute type B aortic dissection patients undergoing thoracic endovascular aortic repair
【24h】

Prognostic dynamic nomogram integrated with metabolic acidosis for in-hospital mortality and organ malperfusion in acute type B aortic dissection patients undergoing thoracic endovascular aortic repair

机译:预后动态载体与代谢酸性中毒,在急性型B主动脉夹层患者中进行临床医院死亡率和器官手术治疗胸腔血管内主动脉修复

获取原文
           

摘要

Organ malperfusion is a lethal complication in acute type B aortic dissection (ATBAD). The aim of present study is to develop a nomogram integrated with metabolic acidosis to predict in-hospital mortality and organ malperfusion in patients with ATBAD undergoing thoracic endovascular aortic repair (TEVAR). The nomogram was derived from a retrospectively study of 286 ATBAD patients who underwent TEVAR from 2010 to 2017 at a single medical center. Model performance was evaluated from discrimination and calibration capacities, as well as clinical effectiveness. The results were validated using a prospective study on 77 patients from 2018 to 2019 at the same center. In the multivariate analysis of the derivation cohort, the independent predictors of in-hospital mortality and organ malperfusion identified were base excess, maximum aortic diameter?≥?5.5?cm, renal dysfunction, D-dimer level?≥?5.44?μg/mL and albumin amount?≤?30?g/L. The penalized model was internally validated by bootstrapping and showed excellent discriminatory (bias-corrected c-statistic, 0.85) and calibration capacities (Hosmer–Lemeshow P value, 0.471; Brier Score, 0.072; Calibration intercept, ??0.02; Slope, 0.98). After being applied to the external validation cohort, the model yielded a c-statistic of 0.86 and Brier Score of 0.097. The model had high negative predictive values (0.93–0.94) and moderate positive predictive values (0.60–0.71) for in-hospital mortality and organ malperfusion in both cohorts. A predictive nomogram combined with base excess has been established that can be used to identify high risk ATBAD patients of developing in-hospital mortality or organ malperfusion when undergoing TEVAR.
机译:器官甘油是急性型B主动脉解剖(阿巴德)的致命并发症。目前研究的目的是开发与代谢酸中毒相结合的NOMA画,以预测患有胸腔内血管主动脉修复(TEVAR)的患者的住院死亡率和器官孕系。罗维图是从2010年至2017年在一个医疗中心完成了286名阿巴德患者的回顾性研究。根据鉴别和校准能力以及临床效果评估模型性能。使用2018年至2019年在同一中心的77名患者的前瞻性研究验证了结果。在衍生队队的多元分析中,鉴定了医院内死亡率和器官孕核的独立预测因子是基础过量的,最大主动脉直径?≥?5.5?cm,肾功能不全,D-二聚体水平?≥≤5.44Ω·μg/ ml和白蛋白量?≤α30?g / l。惩罚模型通过自动启动内部验证,并显示出卓越的歧视性(偏置C统计,0.85)和校准容量(Hosmer-Lemeshow P值,0.471; Brier得分,0.072;校准截距,0.02;斜坡,0.98) 。应用于外部验证队列后,该模型产生了0.86级的C统计,盈利分数为0.097。该模型具有高负预测值(0.93-0.94)和中度阳性预测值(0.60-0.71),用于在医院死亡率和两种队列中的器官手术。已经建立了一种预测的载体,其结合基础过量,可用于识别在接受Tevar时培养医院死亡率的高风险Atbad Atbad Atbad患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号